| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000044302 |
| Receipt No. | R000042857 |
| Scientific Title | Comparison of Continuous Thoracic Epidural and Paravertebral Blocks for postoperative Analgesia and Complications after Minimally Invasive Cardiac Surgery |
| Date of disclosure of the study information | 2021/05/24 |
| Last modified on | 2022/05/02 (Ver. 3) |
| Basic information | ||
| Public title | Comparison of Continuous Thoracic Epidural and Paravertebral Blocks for postoperative Analgesia and Complications after Minimally Invasive Cardiac Surgery | |
| Acronym | Comparison of Continuous Thoracic Epidural and Paravertebral Blocks for postoperative Analgesia and Complications after Minimally Invasive Cardiac Surgery | |
| Scientific Title | Comparison of Continuous Thoracic Epidural and Paravertebral Blocks for postoperative Analgesia and Complications after Minimally Invasive Cardiac Surgery | |
| Scientific Title:Acronym | Comparison of Continuous Thoracic Epidural and Paravertebral Blocks for postoperative Analgesia and Complications after Minimally Invasive Cardiac Surgery | |
| Region |
|
|
| Condition | |||
| Condition | mitral regulation
|
||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To compare continuous thoracic epidural analgesia and paravertebral block for postoperative analgesia in patients undergoing minimally invasive cardiac surgery for quality of analgesia, complications. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The means of postoperative NRS at 0 hours (endotracheal extubation), 2hours and 6hours. |
| Key secondary outcomes | NRS at 12hours, 24hours,48hours after extubation.
NRS at the first time after discharged hospital Hemodynamics during operation Postoperative course: intubation time, ICU stay, hospital stay postoperative complications: re-intubation, Non-invasive positive pressure ventilation, pulmonary complication, arrhythmia(including new onset of atrial fibrillation or flutter), postoperative nausea and vomitting Patient satisfaction Side effects of epidural or paravertebral catheter insertion |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | YES |
| Concealment | Central registration |
| Intervention | |||
| No. of arms | 2 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | epidural block group:
epidural block catheter insertion the day before operation.5ml administration of 0.25% revobupivacane between anesthetic induction and operation starts. 3ml per hour continuous infusion of 0.2% revobupivacaine when cardio-pulmonary bypass starts. The catheter is removed 48hours after extubation. |
||
| Interventions/Control_2 | paravertebral block group:
paravertebral block catheter insertion the day before operation.10ml administration of 0.25% revobupivacane between anesthetic induction and operation starts. 6ml per hour continuous infusion of 0.2% revobupivacaine when cardio-pulmonary bypass starts. The catheter is removed 48hours after extubation. |
||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Adults elective cardiac surgical patients undergoing minimally invasive cardiac surgery with lateral thoracotomy under cardiopulmonary bypass | |||
| Key exclusion criteria | under 18 years
re-operation hepatic disorder renal disorder low platelet coagulation disorder intake of anticoagulant or antiplatelet drugs chest deformity mental illness malignant disease regular use of analgesics use of steroids collagesn disease history of heparin-indused thrombocytopenia allergic to heparin allergic to local anesthetic local infection at puncture site disagree to this study other reasons considered by surgeons or anesthesiologist |
|||
| Target sample size | 100 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Osaka Police Hospital | ||||||
| Division name | Anesthesiology | ||||||
| Zip code | 5430035 | ||||||
| Address | Kitayama-cho 10-31, Tennoji, Osaka | ||||||
| TEL | 0667716051 | ||||||
| chichihoho1008@gmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Osaka Police Hospital | ||||||
| Division name | Anesthesiology | ||||||
| Zip code | 5430035 | ||||||
| Address | Kitayama-cho 10-31, Tennoji, Osaka | ||||||
| TEL | 0667715051 | ||||||
| Homepage URL | |||||||
| chichihoho1008@gmail.com | |||||||
| Sponsor | |
| Institute | Osaka Police Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Osaka police hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Osaka Police Hospital |
| Address | Kitayama-cho 10-31, Tennoji, Osaka |
| Tel | 5430035 |
| chichihoho1008@gmail.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042857 |